209 related articles for article (PubMed ID: 35163316)
1. Metabolites and Genes behind Cardiac Metabolic Remodeling in Mice with Type 1 Diabetes Mellitus.
Kambis TN; Shahshahan HR; Mishra PK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163316
[TBL] [Abstract][Full Text] [Related]
2. Why the diabetic heart is energy inefficient: a ketogenesis and ketolysis perspective.
Mishra PK
Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H751-H755. PubMed ID: 34533402
[TBL] [Abstract][Full Text] [Related]
3. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
4. Cardiac transcriptome profiling of diabetic Akita mice using microarray and next generation sequencing.
Kesherwani V; Shahshahan HR; Mishra PK
PLoS One; 2017; 12(8):e0182828. PubMed ID: 28837672
[TBL] [Abstract][Full Text] [Related]
5. Myostatin inhibition therapy for insulin-deficient type 1 diabetes.
Coleman SK; Rebalka IA; D'Souza DM; Deodhare N; Desjardins EM; Hawke TJ
Sci Rep; 2016 Sep; 6():32495. PubMed ID: 27581061
[TBL] [Abstract][Full Text] [Related]
6. Diabetic myopathy differs between Ins2Akita+/- and streptozotocin-induced Type 1 diabetic models.
Krause MP; Riddell MC; Gordon CS; Imam SA; Cafarelli E; Hawke TJ
J Appl Physiol (1985); 2009 May; 106(5):1650-9. PubMed ID: 19246652
[TBL] [Abstract][Full Text] [Related]
7. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
[TBL] [Abstract][Full Text] [Related]
8. Streptozotocin diabetes increases mRNA expression of ketogenic enzymes in the rat heart.
Cook GA; Lavrentyev EN; Pham K; Park EA
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):307-312. PubMed ID: 27845231
[TBL] [Abstract][Full Text] [Related]
9. Na+/Ca2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway.
LaRocca TJ; Fabris F; Chen J; Benhayon D; Zhang S; McCollum L; Schecter AD; Cheung JY; Sobie EA; Hajjar RJ; Lebeche D
Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H353-67. PubMed ID: 22610174
[TBL] [Abstract][Full Text] [Related]
10. Metabolic remodelling of glucose, fatty acid and redox pathways in the heart of type 2 diabetic mice.
Cortassa S; Caceres V; Tocchetti CG; Bernier M; de Cabo R; Paolocci N; Sollott SJ; Aon MA
J Physiol; 2020 Apr; 598(7):1393-1415. PubMed ID: 30462352
[TBL] [Abstract][Full Text] [Related]
11. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
[TBL] [Abstract][Full Text] [Related]
12. High-cholesterol diet augments endothelial dysfunction via elevated oxidative stress and reduced tetrahydrobiopterin in Ins2(Akita) mice, an autosomal dominant mutant type 1 diabetic model.
Yang XQ; Chen AF
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):764-9. PubMed ID: 19207718
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of hearts from Akita mice suggests that increases in soluble epoxide hydrolase and antioxidative programming are key changes in early stages of diabetic cardiomyopathy.
Dewey S; Lai X; Witzmann FA; Sohal M; Gomes AV
J Proteome Res; 2013 Sep; 12(9):3920-33. PubMed ID: 23848590
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia and hyperlipidemia blunts the Insulin-Inpp5f negative feedback loop in the diabetic heart.
Bai D; Zhang Y; Shen M; Sun Y; Xia Q; Zhang Y; Liu X; Wang H; Yuan L
Sci Rep; 2016 Feb; 6():22068. PubMed ID: 26908121
[TBL] [Abstract][Full Text] [Related]
15. The Ins2Akita mouse as a model of early retinal complications in diabetes.
Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
[TBL] [Abstract][Full Text] [Related]
16. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.
Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827
[TBL] [Abstract][Full Text] [Related]
17. Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction.
Baseler WA; Dabkowski ER; Williamson CL; Croston TL; Thapa D; Powell MJ; Razunguzwa TT; Hollander JM
Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R186-200. PubMed ID: 21048079
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
19. Altered bone microarchitecture in a type 1 diabetes mouse model Ins2
Carvalho FR; Calado SM; Silva GA; Diogo GS; Moreira da Silva J; Reis RL; Cancela ML; Gavaia PJ
J Cell Physiol; 2019 Jun; 234(6):9338-9350. PubMed ID: 30317631
[TBL] [Abstract][Full Text] [Related]
20. Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus.
Hildebrandt N; Colditz J; Dutra C; Goes P; Salbach-Hirsch J; Thiele S; Hofbauer LC; Rauner M
Sci Rep; 2021 Jan; 11(1):1920. PubMed ID: 33479403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
